Atrás
Precio CStone Pharmaceuticals (02616.HK)
Gráfico del Precio de Acciones 02616.HK
CSTONE PHARMA-B (02616.HK)
CStone Pharmaceuticals
HK$0
0%
$0
Mercado cerrado: Jan 28, 16:00:00 HKT
Sin datos aúnEarnings FAQ
¿Cómo se comparó el EPS reciente de 02616.HK con las expectativas?
¿Cómo fue el desempeño de los ingresos de CStone Pharmaceuticals 02616.HK en el último trimestre?
¿Cuál es la estimación de ingresos para CStone Pharmaceuticals?
¿Cuál es la puntuación de calidad de ganancias de CStone Pharmaceuticals?
¿Cuándo informa CStone Pharmaceuticals sus ganancias?
¿Cuáles son las ganancias esperadas de CStone Pharmaceuticals?
¿Superó CStone Pharmaceuticals las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
--
Precio de apertura
--
Rango del día
-
Rango de 52 semanas
-
Volumen
--
Volumen promedio
11.5M
EPS (TTM)
-0.32
Rendimiento de dividendos
--
Cap. de mercado
--
¿Qué es CSTONE PHARMA-B?
Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 93 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The firm is also engaged in the development and commercialization of immuno-oncology. The firm primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved